Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abdominal, ACH, adjudication, advice, aforementioned, ammonialyase, appointment, ArmaGen, ASH, ataxia, auditor, augment, autosomal, bidding, bispecific, bribery, Cadillac, chance, Chancery, Chondrial, chromatin, circumvent, CMC, CNP, Conference, contemplated, context, contrast, corroborated, coupon, cut, deal, del, Dentistry, devise, disabling, disagree, discourage, disproportionate, doctrine, DQ, duty, elaine, elevated, Eloxx, EMDAC, Endocrinologic, erosion, Esteve, excise, Exposition, fiduciary, flat, foregoing, forum, frataxin, Friedreich, GILTI, Harmonisation, harmonization, harmonize, height, heightened, Hematology, heron, holiday, hombach, Iceland, ICV, identical, Immusoft, inapplicable, interact, Inventiva, Iran, IRC, IRS, John, KyndrisaTM, Liechtenstein, longest, loosen, lump, markedly, marketplace, Memorial, modification, MRI, newly, Norway, OFAC, Orchard, orderly, owed, PAC, Pasi, PCAOB, PEGylated, Pfizer, Presidential, proceed, proportionality, psychological, quotient, Ratification, ratio, Reata, recessive, redact, RegenxBio, repatriated, repatriation, Repligen, revoked, rollover, rose, ROU, roxaparvovec, Sangamo, School, stream, successor, symptomatic, Takeda, taxation, thereof, Thursday, tiered, toll, top, Trustee, UK, unaffected, unapproved, Unobservable, untreated, valoctocogene, variability, viability, Voyager, weekly, WORLDSymposium
Removed:
AAV, adequacy, allocable, ammonia, appeal, approximate, awaiting, bad, British, cancelled, capitalization, Carlo, carve, characterize, composed, concluding, construction, consulting, Controller, defer, derive, devaluation, disposed, District, drisapersen, dwarfism, earning, element, energy, feasibility, finite, fluctuating, formal, gaining, greatest, Greece, Huntington, immunogenicity, induction, invoiced, issuing, Italy, Jersey, lattice, leasehold, liter, lyase, match, methodology, Monte, mortgage, motor, myotonic, Nacetylgalactosamine, neurodegenerative, neuromuscular, OCI, operation, ordinary, originally, PAL, PEG, Pharmacokinetic, placement, play, Portugal, premium, presently, pro, profit, propose, purported, realizability, recovered, redemption, Regeneron, reinstated, renewable, repeat, replaced, retroactively, Russia, salary, score, shareholder, simulation, skipping, sovereign, Spain, SRCC, standardized, stimulate, subprime, tender, titration, tolerability, translation, Turkey, uncollectable, uncollectible, varying, young
Filing tables
Filing exhibits
Related press release
Associated BMRN transcripts
BMRN similar filings
Filing view
External links
Exhibit 21.1
Subsidiaries of BioMarin Pharmaceutical Inc. as of December 31, 2017
Name |
| Direct Parent |
|
| Ownership |
|
| Jurisdiction of Incorporation |
|
BioMarin CNP Ltd. |
| BioMarin Pharmaceutical Inc. |
|
| 100 | % |
| Ireland |
|
BioMarin Commercial Ltd |
| BioMarin Pharmaceutical Inc. |
|
| 100 | % |
| Ireland |
|
BioMarin International Ltd |
| BioMarin Commercial Ltd. |
|
| 100 | % |
| Ireland |
|
BioMarin Leiden Holding BV |
| BioMarin Netherlands Holding Ltd |
|
| 100 | % |
| Netherlands |
|
BioMarin Netherlands Holding Ltd |
| BioMarin Commercial Ltd |
|
| 100 | % |
| Ireland |
|
BioMarin PARP Ltd |
| BioMarin Pharmaceutical Inc. |
|
| 100 | % |
| Ireland |
|